Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Amyloid-β42/Neurogranin Ratio as a Potential Index for Cognitive Impairment in Parkinson’s Disease
Giulia Maria Sancesario, Giulia Di Lazzaro, Mohammad Alwardat, et al.
Journal of Alzheimer s Disease (2020) Vol. 76, Iss. 3, pp. 1171-1178
Closed Access | Times Cited: 15

Showing 15 citing articles:

Clinical and diagnostic implications of Alzheimer’s disease copathology in Lewy body disease
Lorenzo Barba, Samir Abu‐Rumeileh, Henryk Barthel, et al.
Brain (2024) Vol. 147, Iss. 10, pp. 3325-3343
Closed Access | Times Cited: 8
Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
Yaroslau Compta, Tamás Révész
Journal of Parkinson s Disease (2020) Vol. 11, Iss. 1, pp. 107-121
Open Access | Times Cited: 44
CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment
Federico Paolini Paoletti, Lorenzo Gaetani, G. Bellomo, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 15
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson’s disease
Henri Zenuni, Roberta Bovenzi, Jacopo Bissacco, et al.
Neurobiology of Aging (2023) Vol. 131, pp. 24-28
Open Access | Times Cited: 15
A Multi-omics Framework Based on Machine Learning as a Predictor of Cognitive Impairment Progression in Early Parkinson’s Disease
Yang Luo, Yaqin Xiang, Jiabin Liu, et al.
Neurology and Therapy (2025)
Open Access
Tau and Amyloid-β Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters
Tommaso Schirinzi, Henri Zenuni, Piergiorgio Grillo, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 14
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer’s Disease from Other Neurological Disorders
Tommaso Piccoli, Valeria Blandino, Laura Maniscalco, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10831-10831
Open Access | Times Cited: 14
Cerebrospinal fluid protein biomarkers in Parkinson's disease
Mohd Faizan, Nidhi Sachan, O. Prakash Verma, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117848-117848
Closed Access | Times Cited: 2
Effects of head trauma and sport participation in young-onset Parkinson’s disease
Tommaso Schirinzi, Piergiorgio Grillo, Giulia Di Lazzaro, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 8, pp. 1185-1193
Open Access | Times Cited: 17
Associations between cerebrospinal fluid markers and cognition in ageing and dementia: A systematic review
Tyler S. Saunders, Danni A. Gadd, Tara L. Spires‐Jones, et al.
European Journal of Neuroscience (2022) Vol. 56, Iss. 9, pp. 5650-5713
Open Access | Times Cited: 9
Cerebrospinal Fluid Neurofilaments Light-Chain Differentiate Patients Affected by Alzheimer’s Disease with Different Rate of Progression (RoP): A Preliminary Study
Valeria Blandino, Tiziana Colletti, Paolo Ribisi, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 960-960
Open Access | Times Cited: 1
Third ventricular width by transcranial sonography is associated with cognitive impairment in Parkinson's disease
Hongling Gao, Yi Qu, Sheng‐chong Chen, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 3
The Underestimated Relevance of Alzheimer’s Disease Copathology in Amyotrophic Lateral Sclerosis
Lorenzo Barba, Markus Otto, Samir Abu‐Rumeileh
Journal of Alzheimer s Disease (2023) Vol. 95, Iss. 4, pp. 1401-1404
Closed Access | Times Cited: 3
How Comorbidity Reflects on Cerebrospinal Fluid Biomarkers of Neurodegeneration in Aging
Henri Zenuni, Piergiorgio Grillo, Giulia Maria Sancesario, et al.
Journal of Alzheimer s Disease Reports (2021) Vol. 5, Iss. 1, pp. 87-92
Open Access | Times Cited: 4
The Diagnostic Value of Cerebrospinal Fluid Neurogranin in Neurodegenerative Diseases
Daria Krawczuk, Piotr Mroczko, Izabela Winkel, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13578-13578
Open Access
Page 1

Scroll to top